Regan M. Memmott

2.2k total citations
24 papers, 1.7k citations indexed

About

Regan M. Memmott is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Regan M. Memmott has authored 24 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Regan M. Memmott's work include PI3K/AKT/mTOR signaling in cancer (13 papers), Cancer-related Molecular Pathways (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Regan M. Memmott is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (13 papers), Cancer-related Molecular Pathways (6 papers) and Metabolism, Diabetes, and Cancer (6 papers). Regan M. Memmott collaborates with scholars based in United States, Australia and Malaysia. Regan M. Memmott's co-authors include Phillip A. Dennis, Joell J. Gills, Shigeru Kawabata, Jose R. Mercado, Stephen D. Fox, Colleen R. Maier, Brendan Quinn, Hiroshi Kitagawa, Courtney A. Granville and Scot Ebbinghaus and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Regan M. Memmott

24 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Regan M. Memmott United States	14	1.3k	509	312	186	173	24	1.7k
Maria Letizia Motti Italy	21	1.2k 0.9×	757 1.5×	308 1.0×	149 0.8×	126 0.7×	42	1.8k
Susan E. Bray United Kingdom	20	1.1k 0.9×	711 1.4×	405 1.3×	171 0.9×	162 0.9×	40	1.7k
Nicole R. Murray United States	26	1.4k 1.1×	637 1.3×	381 1.2×	186 1.0×	211 1.2×	47	2.1k
Italia Falcone Italy	20	900 0.7×	508 1.0×	362 1.2×	87 0.5×	229 1.3×	39	1.6k
Xisong Ke China	20	1.3k 1.0×	533 1.0×	503 1.6×	106 0.6×	213 1.2×	54	2.0k
Fabiola Moretti Italy	25	1.1k 0.9×	650 1.3×	270 0.9×	95 0.5×	129 0.7×	59	1.7k
Oona Delpuech United Kingdom	20	1.1k 0.8×	433 0.9×	460 1.5×	162 0.9×	243 1.4×	33	1.7k
Kyung Song United States	22	1.1k 0.9×	341 0.7×	280 0.9×	68 0.4×	171 1.0×	50	1.6k
Oliver Treeck Germany	25	734 0.6×	543 1.1×	340 1.1×	67 0.4×	115 0.7×	87	1.7k
Anna Garuti Italy	21	644 0.5×	477 0.9×	254 0.8×	123 0.7×	117 0.7×	67	1.5k

Countries citing papers authored by Regan M. Memmott

Since Specialization

Citations

This map shows the geographic impact of Regan M. Memmott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Regan M. Memmott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Regan M. Memmott more than expected).

Fields of papers citing papers by Regan M. Memmott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Regan M. Memmott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Regan M. Memmott. The network helps show where Regan M. Memmott may publish in the future.

Co-authorship network of co-authors of Regan M. Memmott

This figure shows the co-authorship network connecting the top 25 collaborators of Regan M. Memmott. A scholar is included among the top collaborators of Regan M. Memmott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Regan M. Memmott. Regan M. Memmott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johns, Natalie, Songzhu Zhao, Po‐Lan Su, et al.. (2025). CLO25-080: Outcomes of Extreme Low PD-L1 Expression in Advanced Non-Small Cell Lung Cancer: Implications for Treatment Approaches. Journal of the National Comprehensive Cancer Network. 23(3.5). 1 indexed citations

Kwon, Hyunwoo, Mingjia Li, Anjun Ma, et al.. (2024). Eosinophil-neutrophil ratio as a sex-dependent prognostic marker in immune checkpoint therapy for metastatic NSCLC and transcriptomic evaluation of intratumoral eosinophil-T cell interaction.. Journal of Clinical Oncology. 42(16_suppl). 8586–8586. 1 indexed citations

Farid, Saira, Ming Li, Lai Wei, et al.. (2024). EP.12B.10 Patterns and Clinical Impact of Alectinib Dose Reduction in Patients with ALK-Positive Non- Small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology. 19(10). S644–S645. 1 indexed citations

Owen, Dwight H., Regan M. Memmott, Gregory A. Otterson, et al.. (2023). Novel STK11 differentiation phenotype classifier STK11-DPC: Immunosuppressive tumor microenvironment (TME) and response to immune checkpoint blockade (ICB) in STK11-deficient NSCLC.. Journal of Clinical Oncology. 41(16_suppl). 2626–2626. 1 indexed citations

Farid, Saira, Songzhu Zhao, Sandip H. Patel, et al.. (2023). Real world outcomes of patients treated with first line chemo-immunotherapy (IO) for small cell lung cancer (SCLC): Impact of brain metastases and patterns of subsequent therapy.. Journal of Clinical Oncology. 41(16_suppl). e20639–e20639. 1 indexed citations

Memmott, Regan M., Adam R. Wolfe, David P. Carbone, & Terence M. Williams. (2021). Predictors of Response, Progression-Free Survival, and Overall Survival in Patients With Lung Cancer Treated With Immune Checkpoint Inhibitors. Journal of Thoracic Oncology. 16(7). 1086–1098. 67 indexed citations

Komiya, Takefumi, Regan M. Memmott, Gideon M. Blumenthal, et al.. (2019). A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer. Translational Lung Cancer Research. 8(3). 247–257. 12 indexed citations

Komiya, Takefumi, Gideon M. Blumenthal, Marc Ballas, et al.. (2019). A Pilot Study of Sirolimus in Subjects with Cowden Syndrome or Other Syndromes Characterized by Germline Mutations in PTEN. The Oncologist. 24(12). 1510–e1265. 43 indexed citations

Kawabata, Shigeru, Chun-Te Chiang, Junji Tsurutani, et al.. (2014). Rapamycin downregulates thymidylate synthase and potentiates the activity of pemetrexed in non-small cell lung cancer. Oncotarget. 5(4). 1062–1070. 27 indexed citations

10.

Quinn, Brendan, Matthew C. Dallos, Hiroshi Kitagawa, et al.. (2013). Inhibition of Lung Tumorigenesis by Metformin Is Associated with Decreased Plasma IGF-I and Diminished Receptor Tyrosine Kinase Signaling. Cancer Prevention Research. 6(8). 801–810. 68 indexed citations

11.

Quinn, Brendan, Hiroshi Kitagawa, Regan M. Memmott, Joell J. Gills, & Phillip A. Dennis. (2013). Repositioning metformin for cancer prevention and treatment. Trends in Endocrinology and Metabolism. 24(9). 469–480. 232 indexed citations

12.

Memmott, Regan M., Jose R. Mercado, Colleen R. Maier, et al.. (2010). Metformin Prevents Tobacco Carcinogen–Induced Lung Tumorigenesis. Cancer Prevention Research. 3(9). 1066–1076. 345 indexed citations

13.

Memmott, Regan M. & Phillip A. Dennis. (2009). The Role of the Akt/mTOR Pathway in Tobacco Carcinogen–Induced Lung Tumorigenesis. Clinical Cancer Research. 16(1). 4–10. 66 indexed citations

14.

Granville, Courtney A., Regan M. Memmott, Jacopo Mariotti, et al.. (2009). A Central Role for Foxp3+ Regulatory T Cells in K-Ras-Driven Lung Tumorigenesis. PLoS ONE. 4(3). e5061–e5061. 66 indexed citations

15.

Han, Wei, Joell J. Gills, Regan M. Memmott, Stephen Lam, & Phillip A. Dennis. (2009). The Chemopreventive Agent Myoinositol Inhibits Akt and Extracellular Signal-Regulated Kinase in Bronchial Lesions from Heavy Smokers. Cancer Prevention Research. 2(4). 370–376. 36 indexed citations

16.

Memmott, Regan M. & Phillip A. Dennis. (2009). Akt-dependent and -independent mechanisms of mTOR regulation in cancer. Cellular Signalling. 21(5). 656–664. 317 indexed citations

17.

Memmott, Regan M., Joell J. Gills, Melinda G. Hollingshead, et al.. (2008). Phosphatidylinositol Ether Lipid Analogues Induce AMP-Activated Protein Kinase–Dependent Death in LKB1-Mutant Non–Small Cell Lung Cancer Cells. Cancer Research. 68(2). 580–588. 41 indexed citations

18.

Palumbo, SunMi L., et al.. (2008). A novel G-quadruplex-forming GGA repeat region in the c-myb promoter is a critical regulator of promoter activity. Nucleic Acids Research. 36(6). 1755–1769. 156 indexed citations

19.

Gills, Joell J., S. Sianna Castillo, Chunyu Zhang, et al.. (2007). Phosphatidylinositol Ether Lipid Analogues That Inhibit AKT Also Independently Activate the Stress Kinase, p38α, through MKK3/6-independent and -dependent Mechanisms. Journal of Biological Chemistry. 282(37). 27020–27029. 44 indexed citations

20.

Granville, Courtney A., Regan M. Memmott, Joell J. Gills, & Phillip A. Dennis. (2006). Handicapping the Race to Develop Inhibitors of the Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin Pathway. Clinical Cancer Research. 12(3). 679–689. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact